Is Juvenile Diabetes a Viral Disease?

References

• Maugh TH. Diabetes: epidemiology suggests a viral connection. Science 1975; 188: 347–51.
   PubMed Web of Science ®Google Scholar
• Harris M. A case of diabetes mellitus quickly following mumps. Boston Med Surg 1899; 140: 465.
   Google Scholar
• Hyöty H, Leinikki P, Reunanen A, Ilonen J, Surcel H-M, Rilva A. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res 1988; 9: 111–6.
   PubMedGoogle Scholar
• Gundersen E. Is diabetes of infectious origin? J Intect Dis 1927; 41: 197–202.
   Google Scholar
• Ratzmann KP, Strese J, Witt S, Berling H, Keilacker H, Michaelis D. Mumps infection and insulin dependent diabetes mellitus (IDDM). Diabetes Care 1984; 7: 170–3.
   PubMedGoogle Scholar
• Ginsberg-Fellner F, Witt ME, Fedun B, et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 1985; 7 suppl. 1: 170–6.
   Google Scholar
• Gamble DR, Taylor K. Seasonal incidence of diabetes mellitus. Br Med J 1969; 3: 631–3.
   PubMedGoogle Scholar
• Friman G, Fohlman J, Frisk G, et al. An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Acta Paediatr Scand 1985; 320: 14–19.
   Google Scholar
• Elamin A. Childhood type 1 (insulin-dependent) diabetes mellitus in the Sudan. Thesis, Uppsala University, 1992; 348.
   Google Scholar
• Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, Taylor KW. Viral antibodies in diabetes mellitus. Br Med J 1969; 3: 627–30.
   PubMed Web of Science ®Google Scholar
• Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173–9.
   PubMed Web of Science ®Google Scholar
• Dahlquist G, Blom L, Holmgren G. The epidemiology of diabetes in Swedish children 0–14 years: a 6-year prospective study. Diabetologia 1985; 28: 802–8.
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390–8.
   PubMed Web of Science ®Google Scholar
• King M, Bidwell D, Shaikh A, Voller A, Banatvala J. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type 1) diabetes mellitus. Lancet 1983; i: 1397–9.
   Google Scholar
• Frisk G, Fohlman J, Kobbah M, et al. High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity. J Med Virol 1985; 17: 219–27.
   PubMed Web of Science ®Google Scholar
• Tuvemo T, Frisk G, Friman G, Ludvigsson J, Diderholm H. IgM against Coxsackie B viruses in children developing type 1 diabetes mellitus: a 7-year retrospective study. Diabetes Res 1988; 9: 125–9.
   PubMedGoogle Scholar
• Tuvemo T, Dahlquist G, Frisk G, et al. The Swedish childhood diabetes study III: IgM against Coxsackie B viruses in newly diagnosed Type 1 (insulin-dependent) diabetic children — no evidence of increased antibody frequency. Diabetologia 1989; 32: 745–7.
   PubMed Web of Science ®Google Scholar
• Frisk G, Nilsson E, Tuvemo T, Friman G, Diderholm H. The possible role of Coxsackie A and ECHO viruses in the pathogenesis of type 1 diabetes mellitus studied by IgM analyses. J Infect 1992; 24: 13–22.
   PubMed Web of Science ®Google Scholar
• Cavallo MG, Baroni MG, Tot A, et al. Viral infection induces cytokine release by beta islet cells. Immunology 1992; 75: 664–8.
   PubMed Web of Science ®Google Scholar
• Cavallo MG, Pozilli P, Bird C, et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 1991; 86: 256–9.
   PubMed Web of Science ®Google Scholar
• Ilonen J, Herva E, Tiilikainen A, Åkerblom HK, Koivukangas T, Kouvalainen K. HLA-Dw2 as a maker of resistance against juvenile diabetes mellitus. Tissue Antigens 1987; 11: 144–6.
   Google Scholar
• Fohlman J, Bohme J, Rask L, et al. Matching of host genotype and serotypes of Coxsackie B virus in the development of juvenile diabetes. Scand J Immunol 1987; 26: 105–10.
   PubMed Web of Science ®Google Scholar
• Foster DW. Diabetes mellitus. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD, eds. Harrison's Principles of Internal Medicine. 10th edn. McGraw-Hill, London, 1984: 661–79.
   Google Scholar
• Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992; 70: 1035–48.
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS. Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986; 314: 1360.
   PubMed Web of Science ®Google Scholar
• Khalil I, D'Auriol L, Gobet M, et al. A combination of HLA-DQbeta Asp57-negative and HLADQalfa Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990; 85: 1315–9.
   PubMed Web of Science ®Google Scholar
• Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infections triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65: 319–31.
   PubMed Web of Science ®Google Scholar
• Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S. Secondary enterovirus infection in the murine model of myocarditis. AJP 1990; 136: 669–81.
   Google Scholar
• Gauntt CJ, Arizpe HM, Higdon AL, Rozek MM, Crawley R, Cunningham MW. Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential. Eur Heart J 1991; 12 (Suppl. D): 124–9.
   PubMedGoogle Scholar
• Beisel KW, Srinivasappa J, Olsen MR, Stiff AC, Essani K, Prabhakar BS. A neutralizing monoclonal antibody against Coxsackie B4 cross-reacts with contractile muscle proteins. Microb Pathog 1990; 8: 151–6.
   PubMed Web of Science ®Google Scholar
• Cunningham M, Antone S, Gulizia J, McManus B, Fischetti V, Gauntt C. Cytotoxic and viral neutralizing antibodies cross-react with streptococcal M protein, enteroviruses and human cardiac myosin. Proc Natl Acad Sci 1992; 89: 1320–4.
   PubMed Web of Science ®Google Scholar
• Modlin J. Coxsackieviruses, echoviruses and newer enteroviruses. In: Mandell, Douglas, Benett, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 1367.
   Google Scholar
• Kogon A, Spigland I, Frothingham T. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations of viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol 1969; 89: 51.
   PubMed Web of Science ®Google Scholar
• Muir P, Tilzey AJ, English TAH, Nicholson F, Signy M, Banatvala JE. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet 1989; I; 804–7.
   Google Scholar
• Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H. Coxsackie B virus IgM in children developing insulin dependent diabetes mellitus: evidence for its induction by a recent or current infection. Diabetologia 1992; 35: 249–53.
   PubMed Web of Science ®Google Scholar
• Pauksen K, Ilbäck NG, Friman G, Fohlman J. Therapy of Coxsackie Virus B3-induced myocarditis with WIN 54 954 in different formulations. Scand J Infect Dis 1993 (Suppl. 88): 125–30.
   Google Scholar
• Fohlman J, Ilbäck NG, Friman G, Morein B. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 1990; 8: 381–4.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J. Epidemiology of childhood diabetes in the Baltic area. Nordic Med 1992; 107: 244–6.
   PubMedGoogle Scholar
• Strikas R, Anderson L, Parker R. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970–1983. J Infect Dis 1986; 153: 346–51.
   PubMed Web of Science ®Google Scholar